Latest Insider Transactions at Omega Therapeutics, Inc. (OMGA)
This section provides a real-time view of insider transactions for Omega Therapeutics, Inc. (OMGA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Omega Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Omega Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 02
2023
|
Richard A Young |
SELL
Open market or private sale
|
Direct |
5,000
-0.67%
|
$40,000
$8.0 P/Share
|
|
May 01
2023
|
Richard A Young |
SELL
Open market or private sale
|
Direct |
5,000
-0.67%
|
$40,000
$8.0 P/Share
|
|
Apr 06
2023
|
Richard A Young |
SELL
Open market or private sale
|
Direct |
5,000
-0.66%
|
$40,000
$8.0 P/Share
|
|
Mar 17
2023
|
Richard A Young |
SELL
Open market or private sale
|
Direct |
10,000
-1.31%
|
$80,000
$8.0 P/Share
|
|
Feb 27
2023
|
Flagship Pioneering Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
3,323,310
+35.49%
|
$16,616,550
$5.78 P/Share
|
|
Jan 10
2023
|
Richard A Young |
SELL
Open market or private sale
|
Direct |
20,000
-2.55%
|
$160,000
$8.0 P/Share
|
|
Sep 14
2022
|
Richard A Young |
SELL
Open market or private sale
|
Direct |
10,000
-1.26%
|
$80,000
$8.0 P/Share
|
|
Feb 01
2022
|
Mahesh Karande President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,300
+8.76%
|
$0
$0.53 P/Share
|
|
Aug 03
2021
|
Flagship Pioneering Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
2,352,938
+9.53%
|
$39,999,946
$17.0 P/Share
|
|
Aug 03
2021
|
Flagship Pioneering Inc. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
45,057,482
+50.0%
|
-
|
|
Aug 03
2021
|
David A Berry Director |
BUY
Open market or private purchase
|
Direct |
53,082
+50.0%
|
$902,394
$17.0 P/Share
|
|
Aug 03
2021
|
Roger Sawhney Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
2,941
+50.0%
|
$49,997
$17.0 P/Share
|
|
Aug 03
2021
|
Invus Public Equities, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
875,000
+27.79%
|
$14,875,000
$17.0 P/Share
|
|
Aug 03
2021
|
Invus Public Equities, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
1,323,530
+48.62%
|
-
|
|
Jul 30
2021
|
Invus Public Equities, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
75,000
+50.0%
|
$1,200,000
$16.14 P/Share
|